SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC
Clinical trial NCT05177497 · UNKNOWN
Trial details
- NCT number
- NCT05177497
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-07-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.